Integrating drug effects on individual cardiac ionic currents and cardiac action potentials to understand nonclinical translation to clinical ECG changes.
Ontology highlight
ABSTRACT: Concomitant inhibition of the late Na+ current (INaL) and/or the L-type Ca2+ current (ICaL) has been hypothesized to mitigate hERG block-mediated QTC prolongation. This hypothesis was tested in a clinical trial using drugs selected based on available patch clamp data at the time. The results showed that hERG block-mediated QTC prolongation with dofetilide was shortened by co-administration of lidocaine or mexiletine-drugs that inhibit INaL. However, diltiazem, selected as the preferential ICaL inhibitor, did not shorten hERG block-mediated QTC prolongation by moxifloxacin. Patch clamp results can be sensitive to experimental differences across laboratories. Therefore, this study reexamined th
SUBMITTER: Johannesen L
PROVIDER: S-EPMC12640937 | biostudies-literature | 2025
REPOSITORIES: biostudies-literature
ACCESS DATA